Review




Structured Review

Moderna moderna s covid 19 mrna vaccines
Moderna S Covid 19 Mrna Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/mrna+vaccines/pmc12933839-421-6-6
Average 86 stars, based on 1 article reviews
moderna s covid 19 mrna vaccines - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

other:

Article Title: Viral and non-viral vectors in gene therapy: current state and clinical perspectives
Article Snippet: , SARS-CoV-2 Infection , National Institute of Allergy and Infectious Diseases (NIAID) , Moderna COVID-19 Vaccine , NCT04811664.

Article Title: Present and future prospects of vaccines: protecting humanity against emerging and re-emerging infectious diseases.
Article Snippet: mRNA vaccines, particularly with the help of nanoparticle-based delivery systems, such as lipid nanoparticles (LNPs), have indeed enabled the successful application of Pfizer-BioNTech and Moderna’s COVID-19 vaccines.

Article Title: The impact of vaccine booster doses on specific B- and T-lymphocyte dynamics in Thai healthcare personnel following COVID-19 vaccination
Article Snippet: This finding is consistent with other studies that have shown significant levels of S1- and RBD-specific B-lymphocytes after booster vaccinations with the Oxford-AstraZeneca, Pfizer-BioNTech, or Moderna COVID-19 vaccine , .

Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke
Article Snippet: Compared to the unvaccinated cohort, patients who received the Moderna COVID-19 vaccine did not display significant differences in all-cause mortality, intracranial hemorrhage, venous thromboembolism, acute myocardial infarction, mechanical ventilation, or G -tube placement at 7- and 30-days after hospitalization (Table ).

Article Title: COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response.
Article Snippet: Severe SARS-CoV-2 infection has been partially controlled by vaccination, though issues in duration and breadth of protection remain.. Few studies investigate factors driving diversity in the cellular immune response to vaccination.. Here, we evaluated T-cell immunity in 60 healthy adults and its relationship to vaccine and subject-

Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke.
Article Snippet: Compared to the unvaccinated cohort, patients who received the Moderna COVID-19 vaccine did not display significant differences in allcause mortality, intracranial hemorrhage, venous thromboembolism, acute myocardial infarction, mechanical ventilation, or G-tube placement at 7- and 30-days after hospitalization (Table 2).

Article Title: Vaccination against COVID-19 and Outcomes in Patients with COVID-19 Infection and Stroke
Article Snippet: Within the exposure cohort in TriNetX, 2460 patients received the Pfizer COVID-19 vaccine, and 997 patients received the Moderna COVID-19 vaccine (Supplementary Table and ).

Article Title:
Article Snippet: Slomski A. Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.



Similar Products

86
Moderna moderna s covid 19 mrna vaccines
Moderna S Covid 19 Mrna Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/mrna+vaccines/pmc12933839-421-6-6
Average 86 stars, based on 1 article reviews
moderna s covid 19 mrna vaccines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna january 2026 fda 2025a moderna covid 19 vaccine
January 2026 Fda 2025a Moderna Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/19+2024+2025+covid+moderna+vaccine/pm42240837-236-5-9
Average 86 stars, based on 1 article reviews
january 2026 fda 2025a moderna covid 19 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna covid 19 vaccine
Moderna Covid 19 Vaccine, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/19+covid+moderna+vaccine/pmc13255034-142-13-13
Average 86 stars, based on 1 article reviews
moderna covid 19 vaccine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna covid 19 vaccine recipients
scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and <t>after</t> <t>COVID-19</t> vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
Moderna Covid 19 Vaccine Recipients, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/19+covid+moderna+vaccine/pmc13265532-273-10-10
Average 86 stars, based on 1 article reviews
moderna covid 19 vaccine recipients - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna covid 19 vaccine moderna
scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and <t>after</t> <t>COVID-19</t> vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
Covid 19 Vaccine Moderna, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/19+covid+moderna+vaccine/pm42117531-510-0-2
Average 86 stars, based on 1 article reviews
covid 19 vaccine moderna - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna mrna 1273 covid 19 vaccines
scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and <t>after</t> <t>COVID-19</t> vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
Moderna Mrna 1273 Covid 19 Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/1273+mrna+%D0%B8%D0%BB%D0%B8/pm42092664-269-13-13
Average 86 stars, based on 1 article reviews
moderna mrna 1273 covid 19 vaccines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Moderna moderna covid 19 vaccines
scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and <t>after</t> <t>COVID-19</t> vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.
Moderna Covid 19 Vaccines, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/moderna+covid-19+vaccine/19+covid+moderna+vaccine/pm42070646-54-2-2
Average 86 stars, based on 1 article reviews
moderna covid 19 vaccines - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and after COVID-19 vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.

Journal: Frontiers in Immunology

Article Title: CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV

doi: 10.3389/fimmu.2026.1821444

Figure Lengend Snippet: scRNA-seq of peripheral immune cells. UMAP and clustering analysis of peripheral blood mononuclear cells collected from (a) healthy control donors, (b) PLWH with normal CD4/CD8 ratio, and (c) PLWH with low cells CD4/CD8 ratio before and after COVID-19 vaccinations resulted in the identification of 22 transcriptionally distinct clusters. Individual cells are colored by cluster identity determined by Azimuth reference. Bar plots show the proportion of cells. UMAP plots on the third column represent the total number of cells from all donor samples, and individual cells are colored by ratio group (healthy control: blue; PLWH normal CD4/CD8 ratio: green; PLWH with low cells CD4/CD8 ratio: red; all other cells: gray). Mono, monocytes; CD14, CD14-positive; CD16, CD16-positive; CD4, CD4-positive; CD8, CD8-positive; CD4 CTL, CD4-positive cytotoxic T lymphocytes; CD4/CD8 TEM, CD4-/CD8-positive effector memory T cell; CD4/CD8 TCM, CD4-/CD8-positive central memory T cell; Treg, regulatory T cell; MAIT, Mucosal associated invariant T cell; NK, natural killer cell; ASDC, AXL+ dendritic cell; cDC1, CD141-positive myeloid dendritic cell; cDC2, CD1c-positive myeloid dendritic cell; pDC, plasmacytoid dendritic cell.

Article Snippet: Although the PLWH cohort included both Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine recipients, analyses were restricted to Pfizer-BioNTech due to sample size constraints and the absence of Moderna-vaccinated healthy controls, limiting assessment of platform-specific effects.

Techniques: Control

Network reorganization and redistribution of node degree in immune cell populations following COVID-19 vaccination. (A–L) Protein–protein interaction (PPI) networks constructed from differentially expressed genes in CD4 + T cells, CD8 + T cells, B cells, and monocytes from HC (HC), PLWH with a normal CD4/CD8 ratio, and PLWH with a low CD4/CD8 ratio. Nodes represent genes and are colored by direction of expression change following vaccination (red, upregulated; blue, downregulated). Node size is proportional to node degree (number of interactions). The five most frequently occurring genes across the 12 networks are indicated by dark green arrows. (M) Distribution of node degree (log10 scale) for upregulated and downregulated genes in monocyte networks across conditions. Each point represents a gene, and boxplots summarize the distribution within each group. Statistical significance was assessed using the Wilcoxon rank sum test. Differences in network node degree were not attributable to differences in monocyte cell abundance or transcriptional complexity (supplementary <xref ref-type=Supplementary Figure 2 ). (N) Scatter plots showing the relationship between average log2 fold change (post vs pre vaccination) and PPI node degree in monocytes across conditions. Dashed vertical lines indicate log2FC = 0, and dashed horizontal lines indicate the node-degree cutoff used to define high-degree nodes. Panels are shown on a linear y-axis; in the low CD4/CD8 group, values above the plotting range were truncated for visualization. " width="100%" height="100%">

Journal: Frontiers in Immunology

Article Title: CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV

doi: 10.3389/fimmu.2026.1821444

Figure Lengend Snippet: Network reorganization and redistribution of node degree in immune cell populations following COVID-19 vaccination. (A–L) Protein–protein interaction (PPI) networks constructed from differentially expressed genes in CD4 + T cells, CD8 + T cells, B cells, and monocytes from HC (HC), PLWH with a normal CD4/CD8 ratio, and PLWH with a low CD4/CD8 ratio. Nodes represent genes and are colored by direction of expression change following vaccination (red, upregulated; blue, downregulated). Node size is proportional to node degree (number of interactions). The five most frequently occurring genes across the 12 networks are indicated by dark green arrows. (M) Distribution of node degree (log10 scale) for upregulated and downregulated genes in monocyte networks across conditions. Each point represents a gene, and boxplots summarize the distribution within each group. Statistical significance was assessed using the Wilcoxon rank sum test. Differences in network node degree were not attributable to differences in monocyte cell abundance or transcriptional complexity (supplementary Supplementary Figure 2 ). (N) Scatter plots showing the relationship between average log2 fold change (post vs pre vaccination) and PPI node degree in monocytes across conditions. Dashed vertical lines indicate log2FC = 0, and dashed horizontal lines indicate the node-degree cutoff used to define high-degree nodes. Panels are shown on a linear y-axis; in the low CD4/CD8 group, values above the plotting range were truncated for visualization.

Article Snippet: Although the PLWH cohort included both Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine recipients, analyses were restricted to Pfizer-BioNTech due to sample size constraints and the absence of Moderna-vaccinated healthy controls, limiting assessment of platform-specific effects.

Techniques: Construct, Expressing

BCR repertoire analysis using bulk RNA sequencing. (A) Isotype usage of healthy and PLWH donors before and after COVID-19 vaccinations. (B) The number of similar IGH sequence pairs (Pairs No) before and after vaccination matched to known antibodies from the coronavirus antibody database (CoV-AbDab). Bars represent mean values, and error bars indicate SEM.

Journal: Frontiers in Immunology

Article Title: CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV

doi: 10.3389/fimmu.2026.1821444

Figure Lengend Snippet: BCR repertoire analysis using bulk RNA sequencing. (A) Isotype usage of healthy and PLWH donors before and after COVID-19 vaccinations. (B) The number of similar IGH sequence pairs (Pairs No) before and after vaccination matched to known antibodies from the coronavirus antibody database (CoV-AbDab). Bars represent mean values, and error bars indicate SEM.

Article Snippet: Although the PLWH cohort included both Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine recipients, analyses were restricted to Pfizer-BioNTech due to sample size constraints and the absence of Moderna-vaccinated healthy controls, limiting assessment of platform-specific effects.

Techniques: RNA Sequencing, Sequencing